Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Benmelstobart in Combination With Anlotinib and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial OvariaN, Fallopian Tube, or Primary Peritoneal Cancer

Second Affiliated Hospital, Zhejiang University, School of Medicine · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
ovarian-cancer
ovarian cancer, fallopian tube cancers, primary peritoneal cancer, benmelstobart, anlotinib, oral metronomic cyclophosphamide, epithelial ovarian cancer, fallopian tube cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 898732
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.